Empirical Financial Services, LLC d.b.a. Empirical Wealth Management

Position in ORKA — Oruka Therapeutics, Inc.

CIK 1510434 Seattle, WA

Back to ORKA Full portfolio

Position in ORKA

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$894,131

+$427,176 QoQ

Shares Held

18,229

+18.3% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ORKA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Empirical Financial Services, LLC d.b.a. Empirical Wealth Management holds $8,046,747 across 13 Biotechnology names. ORKA ranks #5 (11.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc.	66,223	$1,639,680
2	INBX	Inhibrx Biosciences, Inc.	22,584	$1,518,322
3	JAZZ	Jazz Pharmaceuticals plc	5,665	$1,070,968
4	PTCT	Ptc Therapeutics, Inc.	13,851	$943,667
5	ORKA	Oruka Therapeutics, Inc. This page	18,229	$894,131
6	EXEL	Exelixis, Inc.	9,450	$405,310
7	VRTX	Vertex Pharmaceuticals Inc / Ma	659	$294,269
8	ACAD	Acadia Pharmaceuticals Inc	12,923	$287,665

All Filings in ORKA

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$894,131	18,229	+18.3%	Shares	Other	2026-05-04
2025-12-31	$466,955	15,406	0.0%	Shares	Sole	2026-01-16
2025-09-30	$296,257	15,406	—	Shares	Sole	2025-11-10
No filing history on record for this holder in this stock.